Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them

123 4 Compounds having neutral endopeptidase (NEP) and/or human soluble endopeptidase (hSEP) inhibitory activity corresponding to the formula 1, wherein the substituents R, R, Rand Rhave the meanings given in the description and also pharmaceutical compositions containing these compounds, in particu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hoeltje, Dagmar, Fischer, Yvan, Ziegler, Dieter, Weske, Michael, Michaelis, Katrin, Karimi-Nejad, Yasmin, Messinger, Josef, Pahl, Axel, Hoefer, Constanze, Ikonomidou, Hrissanthi, Turski, Lechoslaw
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Hoeltje, Dagmar
Fischer, Yvan
Ziegler, Dieter
Weske, Michael
Michaelis, Katrin
Karimi-Nejad, Yasmin
Messinger, Josef
Pahl, Axel
Hoefer, Constanze
Ikonomidou, Hrissanthi
Turski, Lechoslaw
description 123 4 Compounds having neutral endopeptidase (NEP) and/or human soluble endopeptidase (hSEP) inhibitory activity corresponding to the formula 1, wherein the substituents R, R, Rand Rhave the meanings given in the description and also pharmaceutical compositions containing these compounds, in particular pharmaceutical compositions suitable for treating or inhibiting cardiovascular diseases, sexual dysfunction and/or adverse conditions associated with apoptosis.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07262184</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07262184</sourcerecordid><originalsourceid>FETCH-uspatents_grants_072621843</originalsourceid><addsrcrecordid>eNqNjUFOAzEMRWfDAgF38JJKRKKlgm4RArFixR55ErdjkThR7EhML8mVyBQOwOrL_s_P58P3Y-KQE9k0R6dtVGNrRgHW7tpjHfPXjPFzjivws4-5kFgHT43MERNLdiPJEY9UWMi9OfRk7AE9B_A5ldwk6A2Umj2pAkoAFqOaKDAaLUVo3hT2uYJNxLWvqGBF4ywnvkxYU_e2Lsb4a1Veau2DGLKwHJbjdDmc7TEqXf3lxQAvz-9Pr65p6d_E9ONQcYnbh839Zr3b3v0D-QEup2or</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them</title><source>USPTO Issued Patents</source><creator>Hoeltje, Dagmar ; Fischer, Yvan ; Ziegler, Dieter ; Weske, Michael ; Michaelis, Katrin ; Karimi-Nejad, Yasmin ; Messinger, Josef ; Pahl, Axel ; Hoefer, Constanze ; Ikonomidou, Hrissanthi ; Turski, Lechoslaw</creator><creatorcontrib>Hoeltje, Dagmar ; Fischer, Yvan ; Ziegler, Dieter ; Weske, Michael ; Michaelis, Katrin ; Karimi-Nejad, Yasmin ; Messinger, Josef ; Pahl, Axel ; Hoefer, Constanze ; Ikonomidou, Hrissanthi ; Turski, Lechoslaw ; Solvay Pharmaceuticals GmbH</creatorcontrib><description>123 4 Compounds having neutral endopeptidase (NEP) and/or human soluble endopeptidase (hSEP) inhibitory activity corresponding to the formula 1, wherein the substituents R, R, Rand Rhave the meanings given in the description and also pharmaceutical compositions containing these compounds, in particular pharmaceutical compositions suitable for treating or inhibiting cardiovascular diseases, sexual dysfunction and/or adverse conditions associated with apoptosis.</description><language>eng</language><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7262184$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64038</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7262184$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Hoeltje, Dagmar</creatorcontrib><creatorcontrib>Fischer, Yvan</creatorcontrib><creatorcontrib>Ziegler, Dieter</creatorcontrib><creatorcontrib>Weske, Michael</creatorcontrib><creatorcontrib>Michaelis, Katrin</creatorcontrib><creatorcontrib>Karimi-Nejad, Yasmin</creatorcontrib><creatorcontrib>Messinger, Josef</creatorcontrib><creatorcontrib>Pahl, Axel</creatorcontrib><creatorcontrib>Hoefer, Constanze</creatorcontrib><creatorcontrib>Ikonomidou, Hrissanthi</creatorcontrib><creatorcontrib>Turski, Lechoslaw</creatorcontrib><creatorcontrib>Solvay Pharmaceuticals GmbH</creatorcontrib><title>Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them</title><description>123 4 Compounds having neutral endopeptidase (NEP) and/or human soluble endopeptidase (hSEP) inhibitory activity corresponding to the formula 1, wherein the substituents R, R, Rand Rhave the meanings given in the description and also pharmaceutical compositions containing these compounds, in particular pharmaceutical compositions suitable for treating or inhibiting cardiovascular diseases, sexual dysfunction and/or adverse conditions associated with apoptosis.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNjUFOAzEMRWfDAgF38JJKRKKlgm4RArFixR55ErdjkThR7EhML8mVyBQOwOrL_s_P58P3Y-KQE9k0R6dtVGNrRgHW7tpjHfPXjPFzjivws4-5kFgHT43MERNLdiPJEY9UWMi9OfRk7AE9B_A5ldwk6A2Umj2pAkoAFqOaKDAaLUVo3hT2uYJNxLWvqGBF4ywnvkxYU_e2Lsb4a1Veau2DGLKwHJbjdDmc7TEqXf3lxQAvz-9Pr65p6d_E9ONQcYnbh839Zr3b3v0D-QEup2or</recordid><startdate>20070828</startdate><enddate>20070828</enddate><creator>Hoeltje, Dagmar</creator><creator>Fischer, Yvan</creator><creator>Ziegler, Dieter</creator><creator>Weske, Michael</creator><creator>Michaelis, Katrin</creator><creator>Karimi-Nejad, Yasmin</creator><creator>Messinger, Josef</creator><creator>Pahl, Axel</creator><creator>Hoefer, Constanze</creator><creator>Ikonomidou, Hrissanthi</creator><creator>Turski, Lechoslaw</creator><scope>EFH</scope></search><sort><creationdate>20070828</creationdate><title>Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them</title><author>Hoeltje, Dagmar ; Fischer, Yvan ; Ziegler, Dieter ; Weske, Michael ; Michaelis, Katrin ; Karimi-Nejad, Yasmin ; Messinger, Josef ; Pahl, Axel ; Hoefer, Constanze ; Ikonomidou, Hrissanthi ; Turski, Lechoslaw</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_072621843</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Hoeltje, Dagmar</creatorcontrib><creatorcontrib>Fischer, Yvan</creatorcontrib><creatorcontrib>Ziegler, Dieter</creatorcontrib><creatorcontrib>Weske, Michael</creatorcontrib><creatorcontrib>Michaelis, Katrin</creatorcontrib><creatorcontrib>Karimi-Nejad, Yasmin</creatorcontrib><creatorcontrib>Messinger, Josef</creatorcontrib><creatorcontrib>Pahl, Axel</creatorcontrib><creatorcontrib>Hoefer, Constanze</creatorcontrib><creatorcontrib>Ikonomidou, Hrissanthi</creatorcontrib><creatorcontrib>Turski, Lechoslaw</creatorcontrib><creatorcontrib>Solvay Pharmaceuticals GmbH</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Hoeltje, Dagmar</au><au>Fischer, Yvan</au><au>Ziegler, Dieter</au><au>Weske, Michael</au><au>Michaelis, Katrin</au><au>Karimi-Nejad, Yasmin</au><au>Messinger, Josef</au><au>Pahl, Axel</au><au>Hoefer, Constanze</au><au>Ikonomidou, Hrissanthi</au><au>Turski, Lechoslaw</au><aucorp>Solvay Pharmaceuticals GmbH</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them</title><date>2007-08-28</date><risdate>2007</risdate><abstract>123 4 Compounds having neutral endopeptidase (NEP) and/or human soluble endopeptidase (hSEP) inhibitory activity corresponding to the formula 1, wherein the substituents R, R, Rand Rhave the meanings given in the description and also pharmaceutical compositions containing these compounds, in particular pharmaceutical compositions suitable for treating or inhibiting cardiovascular diseases, sexual dysfunction and/or adverse conditions associated with apoptosis.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_07262184
source USPTO Issued Patents
title Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T03%3A43%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Hoeltje,%20Dagmar&rft.aucorp=Solvay%20Pharmaceuticals%20GmbH&rft.date=2007-08-28&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07262184%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true